225 related articles for article (PubMed ID: 22205231)
1. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
[TBL] [Abstract][Full Text] [Related]
2. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.
Eliopoulos N; Zhao J; Bouchentouf M; Forner K; Birman E; Yuan S; Boivin MN; Martineau D
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1288-98. PubMed ID: 20844023
[TBL] [Abstract][Full Text] [Related]
3. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
[TBL] [Abstract][Full Text] [Related]
4. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.
Gao J; Liu R; Wu J; Liu Z; Li J; Zhou J; Hao T; Wang Y; Du Z; Duan C; Wang C
Biomaterials; 2012 May; 33(14):3673-81. PubMed ID: 22361096
[TBL] [Abstract][Full Text] [Related]
5. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation.
Park JW; Cho JW; Joo SY; Kim CS; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
Eur J Pharmacol; 2012 May; 683(1-3):301-9. PubMed ID: 22449373
[TBL] [Abstract][Full Text] [Related]
6. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
[TBL] [Abstract][Full Text] [Related]
7. Infusion of mesenchymal stem cells overexpressing GDNF ameliorates renal function in nephrotoxic serum nephritis.
Huang ZY; Hong LQ; Na N; Luo Y; Miao B; Chen J
Cell Biochem Funct; 2012 Mar; 30(2):139-44. PubMed ID: 22105543
[TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway.
Fang Y; Tian X; Bai S; Fan J; Hou W; Tong H; Li D
Int J Mol Med; 2012 Jul; 30(1):85-92. PubMed ID: 22552764
[TBL] [Abstract][Full Text] [Related]
9. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells.
Qian H; Yang H; Xu W; Yan Y; Chen Q; Zhu W; Cao H; Yin Q; Zhou H; Mao F; Chen Y
Int J Mol Med; 2008 Sep; 22(3):325-32. PubMed ID: 18698491
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
[TBL] [Abstract][Full Text] [Related]
12. Improved viability and activity of neutrophils differentiated from HL-60 cells by co-culture with adipose tissue-derived mesenchymal stem cells.
Park YS; Lim GW; Cho KA; Woo SY; Shin M; Yoo ES; Chan Ra J; Ryu KH
Biochem Biophys Res Commun; 2012 Jun; 423(1):19-25. PubMed ID: 22609208
[TBL] [Abstract][Full Text] [Related]
13. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.
Yuan L; Wu MJ; Sun HY; Xiong J; Zhang Y; Liu CY; Fu LL; Liu DM; Liu HQ; Mei CL
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F207-18. PubMed ID: 20943766
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
[TBL] [Abstract][Full Text] [Related]
15. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.
Tögel F; Hu Z; Weiss K; Isaac J; Lange C; Westenfelder C
Am J Physiol Renal Physiol; 2005 Jul; 289(1):F31-42. PubMed ID: 15713913
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
18. Stromal cells protect against acute tubular injury via an endocrine effect.
Bi B; Schmitt R; Israilova M; Nishio H; Cantley LG
J Am Soc Nephrol; 2007 Sep; 18(9):2486-96. PubMed ID: 17656474
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
